Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

被引：0
|
作者：
Barbara Rossi
Giovanni Schinzari
Giulio Maccauro
Laura Scaramuzzo
Diego Signorelli
Michele A Rosa
Carlo Fabbriciani
Barone Carlo
机构：
[1] Catholic University,Department of Orthopaedics and Traumatology
[2] Agostino Gemelli Hospital,Department of Medical Oncology
[3] Catholic University,Department of Orthopaedics
[4] Agostino Gemelli Hospital,undefined
[5] Messina University,undefined
来源：
BMC Musculoskeletal Disorders | / 11卷
关键词：
Vascular Endothelial Growth Factor; Osteosarcoma; Vascular Endothelial Growth Factor Expression; Local Relapse; High Grade Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
    Wei Zhang
    Qing Zhang
    Ting-Ting Zheng
    Jian-Cun Zhen
    Xiao-Hui Niu
    中华医学杂志英文版, 2016, 129 (21) : 2530 - 2534
  • [42] High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
    Crews, KR
    Liu, T
    Rodriguez-Galindo, C
    Tan, M
    Meyer, WH
    Panetta, JC
    Link, MP
    Daw, NC
    CANCER, 2004, 100 (08) : 1724 - 1733
  • [43] HIGH-DOSE METHOTREXATE TREATMENT AND LIVER-FUNCTION IN PATIENTS WITH OSTEOSARCOMA
    FABBRI, A
    MOTTA, E
    FERRARI, S
    LONGHI, C
    MARCHI, E
    BACCI, G
    FIGUS, E
    MARCHESINI, G
    JOURNAL OF INTERNAL MEDICINE, 1994, 236 (02) : 209 - 214
  • [44] AGE-RELATED PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH OSTEOSARCOMA
    WANG, YM
    SUTOW, WW
    ROMSDAHL, MM
    PEREZ, C
    CANCER TREATMENT REPORTS, 1979, 63 (03): : 405 - 410
  • [45] COMBINATION CHEMOTHERAPY INCLUDING HIGH-DOSE METHOTREXATE AND RADIOTHERAPY, IN THE TREATMENT OF SMALL CELL-CARCINOMA OF THE LUNG
    BURDON, JGW
    HENDERSON, MM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, : 17 - 21
  • [46] Chemotherapy for osteosarcoma without high-dose methotrexate: A 12-year follow-up on 53 patients
    Tunn, Per-Ulf
    Reichardt, Peter
    ONKOLOGIE, 2007, 30 (05): : 228 - 232
  • [47] High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Holmboe, Laila
    Andersen, Anders M.
    Morkrid, Lars
    Slordal, Lars
    Hall, Kirsten Sundby
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) : 106 - 114
  • [48] High-dose methotrexate and beyond: Which is the optimal chemotherapy in PCNSL?
    Ferreri, A. J. M.
    ONKOLOGIE, 2010, 33 : 98 - 98
  • [49] HIGH-DOSE METHOTREXATE BASED IMMUNOCHEMOTHERAPY WITH MAINTENANCE CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND DEFERRED RADIOTHERAPY FOR ELDERLY PRIMARY CNS LYMPHOMA PATIENTS
    Mishima, K.
    Miyake, Y.
    Kobayashi, Y.
    Suzuki, T.
    Adachi, J.
    Fujimaki, T.
    Nishikawa, R.
    NEURO-ONCOLOGY, 2017, 19 : 108 - 109
  • [50] Outpatient High-dose Methotrexate for Osteosarcoma: It's Safe and Feasible, If You Want It
    Hendershot, Eleanor
    Volpe, Jocelyn
    Taylor, Tracey
    Nicksy, Darcy
    Mills, Denise
    Ramachandran, Nivetha
    Shaikh, Furqan
    Riss, Vera
    Grant, Ronald
    Gupta, Abha A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (05) : 394 - 398
12345